Domenico Marco Bonifati

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Predictors of Long-Term Recurrent Vascular Events After Ischemic Stroke at Young Age

Alessandro Pezzini, Mario Grassi, Corrado Lodigiani et al. · Circulation · 2014 · 105 citations · Full text

Association Between Migraine and Cervical Artery Dissection

Valeria De Giuli, Mario Grassi, Corrado Lodigiani et al. · JAMA Neurology · 2017 · 83 citations · Full text

Long-term cyclosporine treatment in a group of severe myasthenia gravis patients

Domenico Marco Bonifati, C. Angelini · Journal of Neurology · 1997 · 60 citations

Medicine, Long-term Cyclosporine Treatment

Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents

Domenico Marco Bonifati, Carlo Ori, Carlo Riccardo Rossi et al. · Cancer Chemotherapy and Pharmacology · 2000 · 55 citations

Chemotherapeutic Agents, Neuromuscular Damage, Surgical Oncology +8